Balchem Corporation BCPC
167.89
0.05
0.03%
as of 25 Sep
- Market cap
- $5.4B
- P/E
- 33.0×
Follow BCPC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
12.06% | 12.86% | 12.68% | 12.79% | |
| 9.16% | 9.49% | 9.55% | 9.77% | ||
ROIC |
9.07% | 9.55% | 9.52% | 9.79% | |
Return on Tangible Assets |
28.96% | 31.23% | 29.30% | 30.04% | |
Average Days of Receivables |
47.37 | 50.53 | 53.24 | 50.07 | |
Free Cash Flow per Share |
(4.15) | 5.37 | 5.52 | 5.37 | |
Free Cash Flow |
(134.03) | 173.34 | 176.25 | 171.38 | |
Capital Expenditures |
(335.63) | (43.21) | (43.91) | (48.24) | |
Piotroski F-Score |
7.00 | 8.00 | 8.00 | 8.00 | |
| Other line items | |||||
Cash ROIC |
13.09% | 14.26% | 14.20% | 14.25% | |
Accounts Receivable Turnover |
8.04 | 7.88 | 7.43 | 7.62 | |
Accounts Payable Turnover |
13.92 | 11.57 | 9.86 | 10.00 | |
Inventory Turnover |
5.18 | 5.08 | 4.62 | 4.47 | |
Average Days of Payables |
26.36 | 33.09 | 38.31 | 37.17 | |
Days of Inventory on Hand |
74.31 | 71.98 | 79.49 | 85.24 | |
Tax Rate |
(0.23) | (0.22) | (0.22) | (0.23) | |
Research and Development Expense of Revenue |
1.77% | 1.78% | 1.87% | 1.84% | |
Selling, General and Administrative Expense of Revenue |
13.87% | 13.77% | 14.18% | 14.04% | |
Share Based Compensation of Revenue |
1.79% | 1.74% | 1.85% | 1.81% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.35 | 1.40 | 1.39 | 1.34 | |
Depreciation/Fixed assets |
0.15 | 0.15 | 0.16 | 0.16 | |
Capex/Depreciation |
(7.48) | (0.95) | (0.93) | (1.01) | |
Revenue per Share |
31.41 | 32.15 | 33.11 | 34.04 | |
Operating CF per Share |
6.25 | 6.71 | 6.89 | 6.88 | |
Capex per Share |
(10.40) | (1.34) | (1.37) | (1.51) | |
Capex to Sales |
0.33 | 0.04 | 0.04 | 0.04 | |
Net Profit Margin |
14.72% | 14.93% | 14.95% | 15.14% |
Columns are period end dates